Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Sign in
Sign in

Aura Biosciences Receives Fast Track Designation for Bladder Cancer Candidate

Aura Biosciences Receives Fast Track Designation for Bladder Cancer Candidate
Aura Biosciences’s investigational drug belzupacap sarotalocan (AU-011) has received a Fast Track designation from the FDA as a potential treatment for patients with non-muscle invasive bladder cancer.

AU-011 is a virus-like drug conjugate derived from the human papillomavirus. It is the company’s first investigational virus-like drug conjugate. There are currently no approved targeted therapies for non-muscle invasive bladder cancer.

The company plans on investigating the drug in this indication through a phase 1 clinical trial that is expected to begin later this year.

Aura Biosciences is a biopharmaceutical company aiming to transform the treatment of early-stage tumours to prevent metastasis and improve outcomes for patients with cancer. Aura Biosciences is developing a new class of therapies to selectively target and destroy cancer cells, while leaving surrounding tissue unharmed. Founded: 2009, Headquarters: Cambridge, Massachusetts, United States.

August 12, 2022

https://www.fdanews.com/

0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies